Skip to main content
. 2017 Mar 8;4(1):e000165. doi: 10.1136/bmjresp-2016-000165

Table 3.

Study 2: response to pulmonary rehabilitation in COPD patients who were or were not taking an ACE-I or ARB.

ARB or ACE-I
n=76
No ARB or ACE-I
n=179
p value
ΔFFM (kg) −1.7 (2.7) 1.8 (1.4) 0.21
ΔISWD (m) 104 (21) 63 (15) 0.13
ΔCRQ 16.2 (3.8) 17.7 (2.5) 0.75

ACE-I, ACE inhibitors; ARB, AT II receptor antagonist; FFM, fat free mass; ISWD, incremental shuttle walk test distance; CRQ, chronic respiratory disease questionnaire.

All p>0.05. Data are presented as mean (SD).